Abstract
The recent molecular cloning of μ, δ and κ opiate receptors (1–5) has created new opportunities for the study of opiate receptors. The recent cloning of the human μ receptor (6) has shown that there is a high homology between the predicted human and rat μ receptor sequences, but also some differences in sequence. We therefore sought significant changes in the ligand-selectivity profile of these two receptors expressed in the COS and CHO cell lines under identical assay conditions. We used the novel agonist ligand [ 125I]IOXY-AGO (6β-[ 125Iodo]-3,14-dihydroxy-17-methyl-4,5α-epoxymorphinan) since its high specific activity (2200 Ci/mmol) and high affinity for μ opioid receptors generated a high signal-to-noise ratio with use of relatively few expressing cells. (7). The results indicate substantial similarities in ligand-selectivity profile of the human and rat μ receptors, but also modest differences.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
